In this context, it will be interesting to explore if targeting ERK5 SUMOylation could result in an effective approach to tackle prostate cancer, as well other cancers showing nuclear ERK5 and enhanced SUMO machinery players. Here, MAPK7 is linked to prostate carcinoma.